SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-010734
Filing Date
2015-07-02
Accepted
2015-07-02 16:03:14
Documents
1
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6817
  Complete submission text file 0001179110-15-010734.txt   8424
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Issuer) CIK: 0001140098 (see all company filings)

IRS No.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8201 PRESTON ROAD STE 600 DALLAS TX 75225
Business Address
SHAPIRO ALAN C (Reporting) CIK: 0001194959 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36855 | Film No.: 15969637